Pacira BioSciences (PCRX) Competitors

Pacira BioSciences (NASDAQ:PCRX) and Perrigo (NYSE:PRGO) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Which has more volatility and risk, PCRX or PRGO?

Pacira BioSciences has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.

Which has preferable valuation and earnings, PCRX or PRGO?

Pacira BioSciences has higher earnings, but lower revenue than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacira BioSciences	$705.85M	1.70	-$99.56M	-$2.78	-9.59
Perrigo	$4.37B	0.67	-$171.80M	-$0.58	-36.86

Do analysts recommend PCRX or PRGO?

Pacira BioSciences presently has a consensus target price of $30.83, suggesting a potential upside of 15.70%. Perrigo has a consensus target price of $33.00, suggesting a potential upside of 54.38%. Given Perrigo's higher possible upside, analysts plainly believe Perrigo is more favorable than Pacira BioSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacira BioSciences	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Perrigo	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Is PCRX or PRGO more profitable?

Perrigo has a net margin of -1.86% compared to Pacira BioSciences' net margin of -18.08%. Pacira BioSciences' return on equity of 13.29% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pacira BioSciences	-18.08%	13.29%	6.61%
Perrigo	-1.86%	9.09%	3.96%

Does the media refer more to PCRX or PRGO?

In the previous week, Perrigo had 6 more articles in the media than Pacira BioSciences. MarketBeat recorded 9 mentions for Perrigo and 3 mentions for Pacira BioSciences. Pacira BioSciences' average media sentiment score of 1.39 beat Perrigo's score of 1.06 indicating that Pacira BioSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pacira BioSciences	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Perrigo	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of PCRX or PRGO?

99.7% of Pacira BioSciences shares are owned by institutional investors. Comparatively, 95.9% of Perrigo shares are owned by institutional investors. 6.4% of Pacira BioSciences shares are owned by insiders. Comparatively, 0.7% of Perrigo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Pacira BioSciences beats Perrigo on 10 of the 16 factors compared between the two stocks.